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Summary The effects of doxorubicin on the cellular biochemistry of the HeLa cell using 1H spin echo
nuclear magnetic resonance spectroscopy (NMR) of the intact and viable cell in conjunction with dual
wavelength HPLC of cell lysates is reported. Directly dose-related changes were observed in lactate and
reduced glutathione concentration. Doxorubicin induces a time-dependent depletion of the cytosolic pool of
glutathione and a change in the glycolytic pattern of the cell. The glutathione depletion could be partially
reversed by controlled pre-treatment of the cells with N-acetylcysteine and cysteine, the protection being
linked to the intracellular concentration of the thiol.
The antitumour activity of doxorubicin and other anthra-
cyclines is regarded classically as due to DNA intercalation
and non-covalent binding (Hodgson et al., 1983). However,
recently there has been an increasing interest in the possiblity
that the action is due to an effect on the redox status of the
cell (Yoda et al., 1986; Romine & Kessel, 1986; Russo &
Mitchell, 1985). This mode of action of the anthracyclines is
consistent with their basic chemistry. As quinone derivatives
they initially undergo a one-electron reduction to the semi-
quinone and then a further one electron reduction to the
hydroquinone. The semiquinone can also react with mole-
cular oxygen (Hodgson et al., 1983) to produce the super-
oxide radical anion which is responsible for the extranuclear
toxicity. One effect of free radical formation is the alteration
in plasma membrane fluidity through mediated chain re-
actions which result in the conversion of unsaturated fatty
acids to lipid peroxides, causing cell death (Meyers et al.,
1977). This effect has been quantitated using measurement of
malonaldehyde as an end product of lipid peroxidation
(Ledwozyw et al., 1986). In addition, membrane-binding of
the free radical products of doxorubicin metabolism and the
subsequent alteration in both conformation and function is a
mechanism with some significant implications for cardiac
toxicity and tumour response (Hodgson et al., 1983). Doxo-
rubicin can also act as an alkylating agent since the semi-
quinone derivative can undergo an intramolecular electron
transfer with the release of the daunosamine anion (Hodgson
et al., 1983). However it is not clear which of these actions,
if any, is the dominant process.
The endogenous protective agents which allow scavenging
of free radicals include the predominant intracellular thiol
glutathione (L-y-glutamyl-L-cysteinyl-glycine) (GSH)
(Meister & Anderson, 1983). In general, eukaryotic cells
contain two main pools of glutathione, a large cytoplasmic
pool and a smaller mitochondrial pool which is obligatory
for cell survival (Gaetjens et al., 1984). Thus, drug induced
depletion of the cytoplasmic pool in itself would not be
expected to cause cell death except where there is subsequent
drain on mitochondrial GSH which is derived from the
cytoplasmic pool (Meister, 1984). It has been reported that
there is a dose related decrease in cardiac and hepatic
glutathione after limited exposure to a single dose of doxoru-
bicin (Doroshaw et al., 1979). The concentrations of glutath-
ione and the activity of glutathione-S-transferase in liver and
heart cells play a crucial role in moderating the toxicity of
the compound (Hodgson et al., 1983) since increased glutath-
ione levels may act to protect the cell against free radical
products induced by the action of doxorubicin (Doroshaw et
al., 1979).
Several enzymic methods have been described for the
assay of glutathione in animal tissues especially liver and
kidney (Hazelton & Lang, 1980; Davies et al., 1984), but the
cells must first be disrupted. Chemical assays by their nature
are often specific for one type of molecule and as such a
large amount of information on other metabolites is lost.
HPLC provides detailed quantitative information of a wide
range of molecules including glutathione (both oxidised and
reduced forms) in the cell lysate (Reeve et al., 1980;
Reglinski et al., 1987), however, HPLC requires that the cells
be disrupted prior to analysis. In contrast the 1H spin echo
NMR method is non-invasive requiring none of the prepara-
tive steps used in HPLC and other analytical techniques.
Although less sensitive than other methods, it has other
major advantages in that it can identify selective metabolic
processes directly in the intact viable cell and has been used
in erythrocyte biochemistry (Brown & Campbell, 1980;
Rabenstein et al., 1985; McKay et al., 1986) and more
recently in HeLa cells (Reglinski et al., 1987) to study
cellular glutathione and glycolysis. As an analytical tech-
nique it can be quantitative (Rabenstein et al., 1985), but is
more effective in conjunction with HPLC, where the selec-
tivity of NMR and its sensitivity to molecular conformatio-
nal changes in the intact and viable cell can be supported by
the quantitative in vitro HPLC method. Data obtained via
HPLC can be confidently assigned to cellular activity rather
than artefact and some quantitation may be assigned to the
kinetic measurements made by NMR.
It this study we have used the two techniques to study the
basal concentration of glutathione and lactate, the clearance
in GSH and increase in lactate, which occur following
treatment with doxorubicin, and the concentration related
protective action of cysteine and N-acetyl cysteine against
doxorubicin-induced depletion of glutathione and increase in
anaerobic glycolysis.
Materials and methods
Reagents and chemicals
Tetrabutylammonium hydroxide 40% w/w, reduced gluta-
thione, cysteine and N-acetylcysteine were obtained from
Sigma Chemical Company Ltd (UK), HPLC grade methanol
from Rathburn Chemicals Ltd, Walkerburn (UK),
Deuterium oxide (gold label) from Aldrich Chemical Com-
pany, Resorcinol and other chemical AnalaR grade were
obtained from BDH Chemicals Ltd Poole, Dorset, UK.
EMIT free level filters were obtained from SYVA (UK)
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Ltd, Maidenhead, Berks, UK (these are a preassembled
version of the Amicon MPS-1 ultrafiltration apparatus).
IXRPMI 1640 medium (Dutch modification) (with 20mM
HEPES buffer, I g 1 1 sodium chloride) and trypsin 2.5% in
Hanks balanced salt solution were obtained from Flow
Laboratories (UK); foetal bovine serum (FBS) and L-
glutamine from Gibco (UK) Ltd. Doxorubicin was a gener-
ous gift from Farmitalia (Italy).
Tissue culture
HeLa cells were routinely grown as a monolayer in F120
flasks containing enriched RPMI 1640, supplemented with
20mM HEPES, 1 gI 1 sodium bicarbonate and 6.4gI -1
sodium chloride, 10% FBS (50ml) and 1% v/v glutamine
(Reglinski et al., 1987). Cells were grown at 37°C for 5-6
days. They were removed from the flasks using 10ml 0.25%
trypsin for 30sec, and incubated for a further 15-20min at
37°C and then harvested, washing with culture medium.
Nuclear magnetic resonance (NMR) spectroscopy
Harvested cells were washed twice in physiological saline
2H2O/NaC1 (0.154M) to remove excess media and provide a
deuterium lock for the NMR spectrometer. Excessive wash-
ing can cause severe cell lysis (Levine, 1960). The cells were
transferred to a previously autoclaved 5 mm NMR tube,
with a small amount of saline (2H2O/NaCl, 0.154M) to
produce a suspension of 80% packed cells. The average
sample size was approximately 109 cells in 0.4ml.
A Bruker WM 250MHz Aspect 2000 spectrometer was
used to record all spectra. Spin echo NMR spectra were
obtained using a standard Hahn spin echo pulse sequence
(90°-t-180°-t) with a delay time (t) of 60ms. Samples were
maintained at 20°C during data collection and the data from
2000 complete pulse sequences were accumulated for each
Fourier transform. A small presaturation pulse was applied
to the water frequency prior to accumulation. A typical
spectrum is shown, Figure 1, assignments of the resonances
are as previously reported (Reglinski et al., 1987).
HPLC
HPLC was carried out as previously reported (Reglinski et
al., 1987) with some modifications.
Cells were lysed by the addition of 0.4ml of distilled water
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containing resorcinol (internal standard) using an ultrasonic
probe. The lysate was filtered by centrifuging at 2500rpm
through EMIT free drug level filters designed for the ultra-
filtration of plasma. Twenty p1 filtrate, equivalent to
-3.65 x 105 cells, was injected directly into the HPLC
system.
Separation of the lysate was carried out on a 250 x 4.6mm
(i.d.) column supplied packed with APEX Octadacyl (5pm)
from Jones Chromatography (UK) Ltd, with a guard
column 50 x 4.6mm (i.d.) slurry packed in our laboratory
with ODS Hypersil (5Mm) (Shandon Southern, Chesire,
UK). The eluant was methanol/water/40% w/w tetrabuty-
lammonium hydroxide (100:899: 1). The flow rate was
3ml-1 min, UV spectrophotometric detection was at 200 and
219nm, at 0.06 and 0.03 AUFS respectively using a Waters
490 detector (Waters Associates, (UK) A typical HPLC trace
is shown in Figure 2.
Concentration effect of doxorubicin
HPLC Seven flasks were prepared each containing
7.3 x106 cells in 5ml culture medium. One was used as a
control and the other six were treated with doxorubicin at
concentrations from 0.6-6.0nmol per 106 cells.
After 12h the cells were harvested, centrifuged at 1500rpm
for 10min, washed once with PBS, re-centrifuged and lysed
and analysed by HPLC as above.
NMR Samples were prepared as described above. In all
cases an initial reference spectrum of the culture under study
was recorded prior to the addition of glucose (0.3mg,
[1.66pmol] in 20pl) and doxorubicin at concentrations of 30
and 300pmol per 109 cells. Control experiments were con-
ducted with no doxorubicin present.
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Figure 2 HPLC chromatogram of cell lysate from HeLa cells.
Conditions as in the text.
Chemical shift
Figure 1 NMR spectrum of HeLa cells. Conditions as in the
text.
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Effects of NAC and cysteine on HeLa cells treated with
doxorubicin
HPLC In a second experiment seven flasks were used, each
containing 3.5 x 106 cells in 5ml of culture medium. Five
were treated with doxorubicin (5nmol per 106 cells), four of
these had been pre-treated for one hour with N-acetylcys-
teine (NAC) at concentrations of 0.35, 0.7, 1.4 and 2.8 and
cysteine at concentrations of 1.2, 2.4 and 4.8 imol per 106 cells
respectively. Two were used as controls, one with and one
without NAC (0.325 umol per 106 cells). Cells were harvested
and analysed for GSH as above. This experiment could not
be repeated using NMR since the GSH resonance was low
compared with that obtained from NAC at the concen-
trations used.
Transport of amino acids into HeLa cells
NMR samples were prepared as above. Glycine 1.18 mg
(15.9jmol), cysteine hydrochloride, 1.55mg (9.6ymol) and
glutamate, 2.05mg (13.5ymol) were added as concentrated
solutions (20,1l) to the culture. An initial reference spectrum
was recorded and then mixture treated with doxorubicin,
17pg (30jumol per 109 cells) Spectra were recorded at one
hour time intervals.
NMR theory
The NMR method used in this study is well documented for
the study of erythrocyte biochemistry (Brown & Campbell,
1980; Rabenstein, 1978; Rabenstein & Nakashima, 1979). It
makes use of the Hahn spin echo pulse sequence (90°-t-180°-
t) to create a time delay (2t) between signal generation and
accumulation. Cellular systems can be considered loosely to
consist of two types of NMR active components; large
molecules (e.g., membranes, proteins and nucleic acids) and
small molecules (e.g., cytosolic metabolites and substrates).
The relaxation times of these two categories differ; large
molecules, by virtue of cross relaxation, have short relax-
ation times whereas small molecules have substantially larger
values. The delay time (t=60ms) used is sufficient to allow
the polarisation (signal) from the large molecules to relax
back to equilibrium and thus be absent from the spectrum.
The small molecules, as a direct consequence of their longer
signal life, still provide a resonance line in the NMR
spectrum on completion of the pulse sequence. The spin echo
NMR spectrum of the HeLa cell (Figure 1) is thus an
electronically filtered spectrum comprising the small cytosolic
components exclusively.
The spectra obtained have phase modulated signals, which
precludes the use of signal integration, but the peak heights
do reflect the relative ratios of metabolites. Thus the intro-
duction of a suitable reference compound or the identifi-
cation of an invariant naturally-occurring species allows the
determination of the relative change in concentration of
individual metabolites. Because the spectra are modulated
due to the relaxation process during the spin sequence,
chemical changes at specific sites within molecules can be
observed. An example of this behaviour is the change in
resonance intensity observed in the g2- ,B-methylene reso-
nance in glutathione on oxidation (Brown et al., 1977).
Another important consequence of this technique is that a
species may be removed from the NMR spectrum for two
reasons. It can be metabolised (degraded) or it can interact
with the cell macrostructure. Should the latter occur, the
molecule will change relaxation time and would subsequently
be expected to be filtered from the spectrum (Rabenstein et
al., 1982).
two effects on the HeLa cell. Both HPLC (Figure 3) and
spin echo NMR (Figure 4) detected a rapid dose related
depletion of the cytosolic glutathione pool. Responses similar
to this have been reported, using HPLC, for the hepatic
glutathione levels in rats using azathioprine (Kaplowitz,
1977) and in leukaemia cells using DL-buthionine-S,R,sul-
foximine (Somfai-Relles et al., 1983; Romine & Kessel, 1986;
Crook et al., 1986), however, the non-invasive real time
NMR method is also capable of detecting intracellular
lactate (Figure 5). Thus it is possible to study anaerobic
glycolysis by HeLa cells as a measure of the energy require-
ments of the cell; this is consistent with reports on doxorubi-
cin treated human lymphocytes where respiration is affected
(Nielson et al., 1986) and methotrexate treated leukaemic
cells where glucose uptake and lactate production were
found to be raised (Carpentier et al., 1978).
The HPLC method showed a depletion of glutathione of
up to 88% of the control value after 12h using 6nmol
doxorubicin per 106 cells (Figure 3). This compares with the
80% depletion in hepatic glutathione levels (Kaplowitz,
1977) observed in rats using a single dose of azathioprine
after I h.
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Figure 3 Effect of doxorubicin on the GSH concentration of
HeLa cells as measured by HPLC after 12h exposure.
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Results and discussion
The observed LD50 for doxorubicin in HeLa cells was found
to be 8 nmol per 106 cells. Doxorubicin was found to have
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Figure 4 Effect of different concentrations of doxorubicin on
the GSH concentration in intact HeLa cells as measured by spin
echo NMR. * Control - no Doxorubicin; 0 Doxorubicin -
30nmol per 106 cells; * Doxorubicin - 300nmol per 109 cells.
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Figure 6 Effect of different concentrations of doxorubicin on
the intra-cellular lactate concentration of HeLa cells as measured
by spin-echo NMR. * Control - no doxorubicin; 0 Doxo-
rubicin - 30nmol per 109 cells; A Doxorubicin- 300nmol per
106 cells.
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Figure 5 Doxorubicin induced depletion of GSH in HeLa cells
as measured by spin echo NMR. gn - glutathione; La - Lactate,
Lc - levcine, Pch - phosphorylcholine.
The NMR study showed comparable, but qualitative
results (Figure 4 and 5), unlike the HPLC method, changes
observed in the NMR experiment can be conclusively
assigned to cellular activity in the intact cell by doxorubicin.
The single control used (doxorubicin absent) clearly shows
no change in cytosolic glutathione. It should be stressed that
the cells do remain viable under these conditions (Reglinski
et al., 1987). Inspection of Figure 6 shows clear evidence of
glycolysis through lactate production, however, the maxi-
mum rate of glycolysis would not seem to occur until after
depletion of glutathione is at a severe level (90%) (Figure 4).
The effect of doxorubicin on the glutathione pool takes two
forms. At high doses the glutathione depletes rapidly
(t1/2 =30min), suggesting that glutathione is acting as a
primary sink for the free radicals which doxorubicin gen-
erates and the cellular stress does not occur until this
primary defence has gone. This is consistent with the recent
report that glutathione levels correlate with cellular resis-
tance to doxorubicin (Romine & Kessel, 1986).
The lower dose of doxorubicin depleted the glutathione
pool with a t1/2 of 6h (Figure 4) but there is the added
feature of a lag phase; this could arise from two sources:
(i) Slow intracellular accumulation of anthracycline or
(ii) Anthracycline-initiated free radical response is not
observed until sufficient free radicals have been gene-
rated to deplete the final 10% of GSH (the mitochon-
drial component) which is essential for cell survival
(Gaetjens et al., 1984). The lower dose of doxorubicin
also produced increased glycolysis (Figure 6), but not
to the extent observed with high doses.
NAC treatment increases the cytosolic pool offering a
protective mechanism as indicated by extension of the lactate
lag phase which is coincident with the time required to
deplete the larger cytosolic small thiol concentration (Figure
7). This explanation favours the second of the postulates
outlined above.
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Figure 7 Time course of N-acetylcysteine (NAC) and lactate in
cells pretreated with NAC and later with doxorubicin (measured
by NMR). 0 intracellular lactate; * intracellular NAC.
Neither NMR nor HPLC methods detected an appreciable
increase in oxidised glutathione (GSSG) which can easily be
observed by both methods (Reglinski et al., 1987; Brown et
al., 1977). GSSG produced during free radical scavenging is
rapidly reconverted to GSH so long as adequate glutathione
reductase activity remains. This lack of effect of doxorubicin
on GSSG levels has been noted (Adams et al., 1984) by
disruptive methods. In addition 35% of the GSH in the
cellular pool is in the form of mixed disulphides with both
protein and non-protein sulphydryl compounds. The former
will not be detected by the Hahn spin echo pulse sequence
used here. However, it is clear from the NMR experiments
that there is little or no formation of GSSG as a result of
doxorubicin treatment in the HeLa cell. The expression
shown in equation (1), which is routinely used to explain
radical scavenging by GSH is clearly inoperative in the HeLa
cell under these conditions.
2GSH+2Rd------GSSG+2Rd - +2H + (1)
I -1- I a ----&
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The NMR experiments suggest (indirectly) that the depletion
of cellular GSH arises as a result of its reaction with the
NMR silent sulphydryl population namely the protein-thiol
sites as described by equation (2). It is unlikely that GSH
can provide effective protection to the cell in these forms
(Doroshaw et al., 1979)
Protein-SH+GSH+2Rd------Protein-SSG+2Rd - +2H+
(2)
Treatment of HeLa cells with NAC or cycteine 1 h prior to a
previously effective dose of doxorubicin (5nmol 10-6 cells)
results in a decreased anthracycline effect on GSH (Figure
8). This is thought to occur due to the thiols acting in
concert with glutathione as a radical scavenger. NAC is also
shown to be protective against high dose doxorubicin. In the
presence of NAC, lactate stress is not observed until intra-
cellular NAC concentrations fall to insignificant levels
(Figure 17).
The cells were pretreated with the primary constituents of
glutathione i.e. glutamate, cysteine and glycine in the
presence of low dose doxorubicin, in order to eliminate the
lack of precursors as a cause of reduced synthesis of
glutathione. In the NMR experiment the instrument is tuned
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Figure 8(a) Effect of 1 h pretreatment with N-Acetylcysteine on
the GSH content of HeLa cells treated with doxorubicin
(5nmol per 106 cells) as measured by HPLC after 12h exposure.
Figure 8(b) Effect of 1 h pretreatment with cysteine under the
same conditions.
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Figure 9 Effect of doxorubicin at a concentration of
30nmol per 109 cells on the intracellular concentrations of amino
acids added to the medium. 0 Glycine; A Cysteine; A Gluta-
mate; 0 Lactate.
so as to be more sensitive to moieties inside the cell than to
those outside. As a molecule crosses the membrane barrier it
gives a higher signal in the NMR field and its resonance
intensity increases (Brindle et al., 1979; Brown & Campbell,
1980). Glycine showed the simplest transport characteristics,
passing across the cell membrane barrier into the cytosol.
Glutamate also crosses the membrane, but is a substrate for
intermediary metabolism in HeLa and is consumed post
transport giving a reduction in its resonance intensity. Cys-
teine shows a late fall which could be due to metabolism,
synthesis into glutathione, or its function, at these high
concentrations as a free radical scavenger in its own right.
The fact that the lactate profile in cysteine-treated cells
showed no stress when compared with unprotected cells
exposed to the same concentration of doxorubicin (Figures 6
& 9) indicates that cysteine has some protective effect.
In conclusion these results confirm, using the reliable and
compatible HPLC and NMR methods, that the rapid and
significant effect of Doxorubicin on the intraellular gluta-
thione concentration in intact cultured HeLa cells is not an
artefact of cell disruption.
The initial response of the cell to free radical attack is
expressed directly through the glutathione system, there is,
after a lag, a dose-related rise in anaerobic glycolysis,
supplementation with small thiols delays the onset of this
effect.
We have also shown that pretreatment with cysteine and
N-acetyl cysteine can avert radical damage and that the
protection is related to the intracellular thiol concentration.
The mechanism postulated is one of simple competition, but
may also involve radical quenching at the lipid bilayer. The
effectiveness of the protection provided by glutathione and
other small thiols has yet to be further quantified, and is
under investigation using this system.
We would like to thank the Scottish Home and Health Department
for financial support to JR and the Government of Iraq for support
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